Veeva Systems Inc. (VIE:VEEV)
Austria · Delayed Price · Currency is EUR | Market Cap | 32.38B -18.4% |
| Revenue (ttm) | 2.83B +16.2% |
| Net Income | 802.66M +20.6% |
| EPS | 4.81 +19.7% |
| Shares Out | n/a |
| PE Ratio | 40.35 |
| Forward PE | 24.44 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 190.55 |
| Previous Close | 185.55 |
| Day's Range | 190.55 - 199.35 |
| 52-Week Range | 128.20 - 264.30 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |
About Veeva Systems
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides ... [Read more]
Financial Performance
In fiscal year 2026, Veeva Systems's revenue was $3.20 billion, an increase of 16.34% compared to the previous year's $2.75 billion. Earnings were $908.91 million, an increase of 27.27%.
Financial numbers in USD Financial StatementsNews
Veeva to Release Fiscal 2027 Second Quarter Results on August 26, 2026
PLEASANTON, Calif., Aug. 5, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter ending July 31, 2026 after market close on August 26, 2026.
Veeva initiated with a Buy at Guggenheim
Guggenheim initiated coverage of Veeva (VEEV) with a Buy rating and $232 price target Veeva remains well positioned for long-term growth, supported by its entrenched role in life sciences software,…
Veeva initiated with a Buy at Guggenheim
Guggenheim initiated coverage of Veeva (VEEV) with a Buy rating and $232 price target
Veeva Introduces New EHS Application for Proactive Risk Management and Intelligent Automation
Environmental, health, and safety solution is part of Veeva Quality Cloud and will deliver real-time insights and streamlined workflows PLEASANTON, Calif., June 25, 2026 /PRNewswire/ -- Veeva Systems ...
Veeva price target lowered to $272 from $296 at JPMorgan
JPMorgan analyst Alexei Gogolev lowered the firm’s price target on Veeva (VEEV) to $272 from $296 and keeps an Overweight rating on the shares. The firm adjusted targets in the…
Veeva acquires Copli, launches Veeva Falcon MLR to accelerate content review
Veeva (VEEV) has acquired Copli, a company dealing in agentic medical, legal, and regulatory solutions for the life sciences industry. Copli is now available as Veeva Falcon MLR, an agentic…
Veeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review
Now Available, Veeva Falcon MLR Delivers Agentic MLR TM to Significantly Reduce Manual Effort and Shorten Review Cycles PLEASANTON, Calif. and COPENHAGEN, Denmark, June 23, 2026 /PRNewswire/ -- Veeva...
Veeva Systems Transcript: AGM 2026
The meeting covered director elections and auditor ratification, with no additional proposals or shareholder questions. Voting was conducted online, and results will be filed publicly on Form 8-K.
UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
End-to-end safety foundation to speed case processing and enable automation PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that UCB is unifying its global ...
Veeva price target lowered to $270 from $295 at Mizuho
Mizuho analyst Steven Valiquette lowered the firm’s price target on Veeva (VEEV) to $270 from $295 and keeps an Outperform rating on the shares. The firm updated the company’s model…
Morgan Stanley has ‘constructive bias’ on Veeva at current levels
Morgan Stanley maintains an Equal Weight rating and $215 price target on Veeva (VEEV) shares, but says it has “a constructive bias at these levels” following what the firm calls…
Veeva price target lowered to $235 from $300 at TD Cowen
TD Cowen lowered the firm’s price target on Veeva (VEEV) to $235 from $300 and keeps a Buy rating on the shares. The fiscal Q1 revenue beat and raise suggests…
Veeva price target lowered to $185 from $240 at Evercore ISI
Evercore ISI lowered the firm’s price target on Veeva (VEEV) to $185 from $240 and keeps an In Line rating on the shares. After “steady” fiscal Q1 results, the focus…
Veeva price target lowered to $190 from $220 at UBS
UBS analyst Karl Keirstead lowered the firm’s price target on Veeva (VEEV) to $190 from $220 and keeps a Neutral rating on the shares. Veeva’s “mixed” print won’t bend the…
Veeva price target lowered to $175 from $220 at BMO Capital
BMO Capital lowered the firm’s price target on Veeva (VEEV) to $175 from $220 and keeps a Market Perform rating on the shares after its Q1 results. The quarter’s upside…
Veeva price target lowered to $230 from $245 at Stifel
Stifel analyst David Grossman lowered the firm’s price target on Veeva (VEEV) to $230 from $245 and keeps a Buy rating on the shares. The firm adjusted estimates but said…
Veeva price target raised to $260 from $250 at Baird
Baird raised the firm’s price target on Veeva (VEEV) to $260 from $250 and keeps an Outperform rating on the shares. The firm updated its model following its beat and…
Veeva price target lowered to $220 from $235 at Canaccord
Canaccord analyst David Hynes lowered the firm’s price target on Veeva (VEEV) to $220 from $235 and keeps a Hold rating on the shares. The firm said Veeva continues to…
Veeva price target raised to $320 from $317 at Wells Fargo
Wells Fargo raised the firm’s price target on Veeva (VEEV) to $320 from $317 and keeps an Overweight rating on the shares. The firm cites the Q1 beat & raise,…
Veeva price target lowered to $235 from $285 at Piper Sandler
Piper Sandler lowered the firm’s price target on Veeva (VEEV) to $235 from $285 and keeps an Overweight rating on the shares. The firm notes the company posted solid Q1…
Veeva price target lowered to $165 from $190 at Goldman Sachs
Goldman Sachs analyst Adam Hotchkiss lowered the firm’s price target on Veeva (VEEV) to $165 from $190 and keeps a Sell rating on the shares. The company delivered a modest…
Veeva Systems Earnings Call Transcript: Q1 2027
Revenue and operating income exceeded guidance, driven by strong execution in AI, CRM, and Crossix. Ostro acquisition and Falcon AI platform signal continued innovation, while guidance remains conservative amid early-stage scaling of key R&D products.
Veeva Systems Earnings release: Q1 2027
Veeva Systems released its Q1 2027 earnings on June 3, 2026, summarizing the period's financial results.
Veeva Systems Slides: Q1 2027
Veeva Systems has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on June 3, 2026.
Veeva Systems Quarterly report: Q1 2027
Veeva Systems has published its Q1 2027 quarterly earnings report on June 3, 2026.